Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results
Go back to Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results| (NASDAQ: CNTX) | Delayed: 0.52 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.52 | 52 Week High | $ | |||
| Open | $0.53 | 52 Week Low | $ | |||
| Day High | $0.53 | P/E | N/A | |||
| Day Low | $0.52 | EPS | $ | |||
| Volume | 161,042 | |||||

